The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(3-Bromo-4-fluoro-phenyl)-5-methyl-1,1-dioxo-2,3,4,7-tetrahydro-1H-1lambda*6*-thieno[3,2-b]pyridine-6-carboxylic acid methyl ester ID: ALA3138606
PubChem CID: 11418604
Max Phase: Preclinical
Molecular Formula: C16H15BrFNO4S
Molecular Weight: 416.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)C1=C(C)NC2=C(C1c1ccc(F)c(Br)c1)S(=O)(=O)CC2
Standard InChI: InChI=1S/C16H15BrFNO4S/c1-8-13(16(20)23-2)14(9-3-4-11(18)10(17)7-9)15-12(19-8)5-6-24(15,21)22/h3-4,7,14,19H,5-6H2,1-2H3
Standard InChI Key: RVQFARKUFXYKQN-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
2.6559 0.4800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4201 0.7785 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2253 0.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9232 0.8545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6985 -0.3351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2686 -0.4224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0094 -0.7923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8801 1.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4922 0.7879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4976 -0.5435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9412 0.1428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1391 2.0520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2435 0.8216 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8113 1.3347 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0956 2.8837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7934 3.3330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5697 2.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4491 1.6113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5266 2.9503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3629 3.2582 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-0.2016 0.3388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5791 -0.8714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7503 4.1565 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.9343 0.7133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 4 1 0
4 1 1 0
5 1 2 0
6 7 1 0
7 5 1 0
8 4 1 0
9 3 1 0
10 5 1 0
11 2 1 0
12 8 2 0
13 2 2 0
14 2 2 0
15 12 1 0
16 19 1 0
17 8 1 0
18 9 2 0
19 17 2 0
20 15 1 0
21 9 1 0
22 6 1 0
23 16 1 0
24 21 1 0
11 10 1 0
3 6 2 0
15 16 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.27Molecular Weight (Monoisotopic): 414.9889AlogP: 2.75#Rotatable Bonds: 2Polar Surface Area: 72.47Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 1.05CX LogD: 1.05Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: -1.05
References 1. Carroll WA, Altenbach RJ, Bai H, Brioni JD, Brune ME, Buckner SA, Cassidy C, Chen Y, Coghlan MJ, Daza AV, Drizin I, Fey TA, Fitzgerald M, Gopalakrishnan M, Gregg RJ, Henry RF, Holladay MW, King LL, Kort ME, Kym PR, Milicic I, Tang R, Turner SC, Whiteaker KL, Yi L, Zhang H, Sullivan JP.. (2004) Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions., 47 (12): [PMID:15163196 ] [10.1021/jm030356w ]